The patient was originally diagnosed with bi-lateral ER+/HER2− breast cancer (invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) [22] (Figure S1). This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.